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1  | INTRODUC TION
The relevance of the endothelium as the first line of xenogeneic reac-
tion has been recognized for some time. In the endeavor to understand 
mechanisms of hyperacute rejection (HAR) in discordant xenotrans-
plantation, it became apparent that the situation a porcine graft faces 
in the first minutes after transplantation into a primate can be roughly 
recapitulated in vitro by the challenge of porcine endothelial cells 
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Abstract
The activation of the endothelial surface in xenografts is still a poorly understood 
process and the consequences are unpredictable. The role of Ca2+-messaging during 
the activation of endothelial cells is well recognized and routinely measured by syn-
thetic Ca2+-sensitive fluorophors. However, these compounds require fresh loading 
immediately before each experiment and in particular when grown in state-of-the-art 
3D	cell	culture	systems,	endothelial	cells	are	difficult	 to	access	with	such	sensors.	
Therefore, we developed transgenic pigs expressing a Ca2+-sensitive protein and ex-
amined its principal characteristics. Primary transgenic endothelial cells stimulated 
by ATP showed a definite and short influx of Ca2+ into the cytosol, whereas exposure 
to	human	serum	resulted	in	a	more	intense	and	sustained	response.	Surprisingly,	not	
all endothelial cells reacted identically to a stimulus, rather activation took place in 
adjacent cells in a timely decelerated way and with distinct intensities. This effect 
was again more pronounced when cells were stimulated with human serum. Finally, 
we show clear evidence that antibody binding alone significantly activated endothe-
lial cells, whereas antibody depletion dramatically reduced the stimulatory potential 
of serum. Transgenic porcine endothelial cells expressing a Ca2+-sensor represent 
an interesting tool to dissect factors inducing activation of porcine endothelial cells 
after exposure to human blood or serum.
K E Y W O R D S
antibody depletion, complement activation, genetically encoded Ca2+-sensor, porcine 
endothelial cell activation
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(ECs)	with	human	serum.1,2 Moreover, the quantitative relationship of 
antibody deposition on the endothelial surface and activation of the 
complement system could be identified as major drivers of HAR.3 Very 
soon, it became evident that the genetic modification of the donor, 
that is, the pig, would be the most promising approach to overcome 
antibody-mediated damage of the endothelium. Initially, additive 
transgenes expressing human complement regulatory proteins (hCRP) 
were introduced into the porcine genome,4 aiming at suppressing the 
complement activation cascade that is triggered by antibody deposi-
tion. Although significant improvement was achieved by combinations 
of hCRP in pig-to-primate experiments,5 HAR was finally overcome by 
eliminating the most relevant xenoepitope recognized by preformed 
human	antibodies	on	porcine	EC,	α1,3-galactosyl-galactose (aGal), by 
deleting the responsible gene GGTA1 (GTKO).6,7 More recently, it was 
shown that expression of a human thrombomodulin (hTBM) transgene 
overcomes incompatibilities in the coagulation system between the 
human (or primate) bloodstream and the porcine endothelium 8 and 
additionally prevents inflammatory-induced activation of endothelial 
cells.9 The combination of GTKO.hCRP.hTBM with sophisticated im-
munosuppression and prevention of ischemia/reperfusion injury pro-
longed survival of a porcine heart heterotopically transplanted into a 
baboon for 2.5 years.10 Furthermore, it facilitated the survival of ba-
boon recipients after fully life-supporting orthotopic heart transplan-
tation for 6 months.11 In another study, life-sustaining transplantation 
of porcine kidneys into macaques was achieved by a combination of 
only GTKO.hCRP,12 whereas the hTBM transgene proved essential in 
cardiac transplantation.13 In contrast, attempts to transplant other 
vascularized organs such as liver or lung trail far behind.14,15 In both 
cases, the poor outcome has been at least partially associated with in-
sufficiently controlled endothelial activation.16,17 Thus, our general un-
derstanding of endothelial function or failure in xenografts is far from 
satisfactory. There is evidence that the endothelium experiences sig-
nificant acute or chronic challenges even in the best possible current 
circumstances: (a) Although downstream activation of complement is 
inhibited by hCRP, the ongoing deposition of antibodies and activation 
of initial complement components on the surface of the vessel walls 
might	still	activate	EC.18	(b)	The	direct	activation	of	EC	by	different	leu-
kocyte types 19-21 suggests that additional cellular players deserve at-
tention. (c) The presence of pro-inflammatory cytokines was sufficient 
to activate endothelial cells in the absence of human or primate cells 
or serum.22 (d) The protective function of Corline-Heparin Conjugate 
on	GTKO.hCRP.hTBM	pig	EC	indicates	space	for	further	improvement	
of the xenograft endothelium.23 Finally, the diversity of endothelial 
function and its dynamic regulation has stimulated the definition of 
endothelial subtypes, their characterization by high-end tools, as well 
as their comparative analysis on a high-density data basis.24
Considering these aspects, it is highly relevant to promote re-
search to better understand the status of xenograft endothelium. 
Due	to	the	difficulties	in	assessing	vessel	structures	in	vivo,	improved	
tools for in vitro examination have been developed, such as the es-
tablishment of endothelial-coated vessel-like structures under shear 
stress, that are perfused either under constant 25 or pulsatile flow.26 
Further attention has been paid to the dynamic processes occurring 
during angiogenesis 27,28 or the communication of endothelial cells 
with each other 29 or with other cell types.30 Interestingly, the anal-
ysis	 of	 these	 complex	3D-like	 structures	was	 limited	 to	 a	 post-ex-
perimental single-point readout. This is somewhat surprising, as the 
quantification of intracellular calcium levels by Ca2+-sensitive probes 
is an established tool and many different probes are commercially 
available. Although the loading of tissue such as murine aortas with 
fluorescent Ca2+-sensitive probes was informative,31 the examination 
of three-dimensional endothelial structures in vitro is apparently not 
compatible with the short-term interference of Ca2+-probe loading.
As Ca2+-sensitive proteins might be a valuable alternative, we de-
scribe here the generation of pigs expressing Case12, a genetically en-
coded fluorescent Ca2+-sensor based on green fluorescent protein,32 
and	present	evidence	that	Case12	sensitively	detects	activation	of	EC	
by biologically relevant substrates. It is of note that only complement-in-
activated human serum, but not antibody-depleted serum, triggered cal-
cium	influx	into	the	cytoplasm	of	porcine	EC,	confirming	that	antibody	
depletion alone is sufficient to reduce the activation of endothelial cells.
2  | MATERIAL S AND METHODS
2.1 | Ethical statement
All animal work was carried out with the permission of the respon-
sible authority (Regierung von Oberbayern, AZ55.2-1-54-2531-86-
10)	and	in	accordance	with	§15	TSchG	German	Animal	Welfare	Law.	
Animal experiments included the generation of genetically modified 
animals by somatic cell nuclear transfer. Human blood was taken 
from healthy volunteers.
2.2 | Generation of case12-pigs
For ubiquitous expression of the synthetic Ca2+-sensor, we used 
the	previously	described	CAG-MCS-pA/	neo	plasmid	33 and intro-
duced	the	coding	region	of	Case12	gene	(Evrogen)	via	the	BamHI/
NotI sites in the multiple cloning site (Figure 1A). The generation 
of genetically modified primary cells was performed as previously 
described.34	In	brief,	the	plasmid	was	verified	by	Sanger	sequenc-
ing and prepared endotoxin-free; the CAG-Case12/neo element 
was excised from the backbone and nucleofected into primary 
fetal fibroblasts. Nucleofected cells were seeded and kept under 
G418 selection.35	 Somatic	 cell	 nuclear	 transfer	 (SCNT)	was	 per-
formed according to our routine procedures 36 and activated em-
bryos were transferred to synchronized foster sows. Pregnancies 
were monitored and birth was introduced as described be-
fore.33	 Transgene	expression	was	detected	by	Western	blotting.	
Endothelial	and	fibroblast	cells	were	lysed	in	lysis	buffer	[150	mM	
NaCl,	 50	 mM	 Tris-HCl	 pH	 7.4,	 1%	 NP-40,	 5	 mM	 EDTA,	 1	 mM	
PMSF,	10	mM	NaF,	complete	protease	inhibitor	(Roche)],	and	pro-
tein	concentration	was	determined	by	BCA	assay.	Equal	amounts	
of	total	protein	were	separated	by	8%	SDS-PAGE	under	reducing	
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conditions	and	blotted	to	PVDF	membrane.	CASE12	and	GAPDH	
were detected using rabbit-anti-TAG(CGY)FP 1:20 000 (AB121, 
Evrogen)	 and	 rabbit-anti-GAPDH	 1:3500	 (#2118	 Cell	 Signaling)	
and horseradish peroxidase-coupled polyclonal goat anti-rabbit 
antibodies	 (Jackson	 ImmunoResearch).	 Bound	 antibodies	 were	
visualized	using	ECL	reagent	(RPN2106;	GE	Healthcare).
2.3 | Primary cells
Fibroblast cultures were established from ear samples taken at an 
age of 3 weeks as described elsewhere.35 At an age of 5 months, 
transgenic pigs were sacrificed and aorta samples were taken for 
cultivation of primary endothelial cells as described elsewhere.8 In 
brief, endothelial cells were isolated with 0.1% collagenase II (Life 
Technologies) and cultured on culture dishes coated with 0.1% gela-
tin	in	DMEM	(Life	Technologies)	containing	10%	endothelial	cell	sup-
plements	MV	(Promocell)	and	10%	FCS	(Life	Technologies).	Fixation	
of	 cells	was	performed	 in	4%	paraformaldehyde	 in	PBS	 for	5	min.	
Case12 fluorescence is known to have an excitation maximum of 
491 nm and an emission maximum of 516 nm. Visualization was per-
formed in a Zeiss Axiovision (Carl-Zeiss) using the standard green 
filter with an excitation window of 470/40 nm and an emission win-
dow of 525/50 nm.
F I G U R E  1   Generation of the Case12 
pig model. (A) A ubiquitous CAG promoter 
has been used to drive the expression 
of the Case12 coding region. Positive 
selection was achieved by a floxed neo 
cassette.	(B)	Expression	of	the	Case12	
protein	was	detected	by	Western	blotting	
primary endothelial and fibroblast cells, 
showing different abundance for distinct 
founder animals. (C) Fluorescence 
microscopy revealed Case12 signal even 
without stimulation in cells from highly 
expressing founders (left) but not in low 
expressing	founders	(right)	(Zeiss	filter	Set	
9: ex BP450-490/em LP 515)
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2.4 | Human serum, heat inactivation, and 
immunoabsorption
Human blood was collected from healthy volunteers into poly-
propylene	 tubes	 containing	 glass	 beads	 (S-Monovette,	 Sarstedt,	
Germany) and allowed to clot for 30 min at room temperature. After 
centrifugation at 2000 × g for 10 min at 4°C, the supernatant was 
collected,	stored	in	aliquots	of	1	mL	at	−	80°C,	and	only	thawed	once	
for experimental purposes. In the present study, sera from 3 differ-
ent donors with different blood groups were used both individu-
ally	and	pooled.	Details	are	given	 in	the	respective	figure	 legends.	
Complement was inactivated by heating the sera at 56°C for 30 min. 
Anti-αGal antibodies were depleted as described previously.37 In 
brief, polypropylene mini-columns (Poly Prep, Bio-Rad Laboratories) 
were	 packed	 with	 3	 mL	 of	 PAA-Bdi-Sepharose	 (kind	 gift	 of	 Prof.	
Nicolai Bovin, Moscow, Russia). After flushing the columns with 
50	mL	of	PBS,	they	were	rinsed	with	25	mL	of	0.1M	Glycine-HCl,	pH	
2.3,	and	equilibrated	with	50	mL	of	PBS.	Incubation	with	20	mL	of	a	
5% bovine serum albumin solution was performed at room tempera-
ture for 1 h to block non-specific binding sites. The prepared col-
umns were then immediately used for immunoabsorption of 7 mL of 
human	serum.	Sera	were	allowed	to	run	through	the	columns	under	
gravity flow. The effluent samples were collected in 1-mL fractions. 
Immunoabsorption columns were then regenerated by using 25ml of 
0.1Ml Glycine-HCl pH2.3.
2.5 | Anti-αGal ELISA
The	 ELISA	 for	 detection	 of	 human	 IgM	 and	 IgG	 antibodies	 spe-
cific for the Bdi epitopes was performed as described previously.38 
In	brief,	ELISA	plates	 (96-well	NUNC	MaxiSorp,	NUNC	AB)	were	
coated by overnight incubation at 4°C with 100 µl per well of PAA-
Bdi (from Prof. Bovin, Moscow), in 0.1 M carbonate buffer, pH 9.6. 
The	plates	were	then	washed	with	PBS,	pH	7.4,	containing	0.02%	
Tween 20. Test sera and an internal standard normal human serum 
were	added	at	a	dilution	of	1:40	 in	bovine	serum	albumin	(BSA)-
Tween-20.	 BSA–Tween-20	 instead	 of	 serum	 was	 used	 as	 blank.	
The plates were then incubated on a shaker for 90 min at 37°C. 
Anti-Gal IgM was detected by monoclonal mouse antibody (mAb) 
clone AF6 and IgG with clone 8a4 (both from Abingdon), used at 
1:4000	in	BSA–Tween-20.	Biotinylated	goat	anti-mouse	IgG1	an-
tibody	(1:2000;	Southern	Biotechnology	Associates,	Inc)	and	sub-
sequently streptavidin-alkaline phosphatase conjugate (1:1000; 
Amersham	Life	Science)	were	used	to	detect	the	bound	antibod-
ies.	Optical	densities	 (OD)	were	 read	at	405	nm	 (Infinite	M1000	
spectrophotometer, Tecan).
2.6 | CH50 assay
The activity of the classical pathway of the complement was ana-
lyzed using standard hemolytic complement (CH50) assay with 
sheep	erythrocytes	(Biomerieux).	Sheep	red	blood	cells	were	washed	
in	veronal	buffered	saline	(VBS++)	at	1:30	dilution	until	the	superna-
tant was clear. The erythrocytes were then diluted to achieve the 
density of 109 cells/ml and incubated with rabbit anti-sheep erythro-
cyte	 antibody	 (S1389;	 Sigma-Aldrich)	 for	 20	 min	 at	 37°C.	 After	
washing away the unbound antibodies, the sensitized erythrocytes 
were	resuspended	in	Alsever's	solution	(A3551;	Sigma-Aldrich)	and	
stored at 4°C overnight. The following day, the cells were washed 
again, and the density was adjusted to 108/ml.	Sera	were	then	added	
to a transparent 96-well microplate (Nunc) and incubated with the 
sensitized erythrocytes at 37°C for 60 min. The reaction was 
stopped	with	PBS.	As	control,	erythrocytes	were	 incubated	 in	ve-
ronal	 buffer	 (DGVB++)	 and	 the	 reaction	 was	 stopped	 with	 water	
(T100,	100%	lysis)	or	PBS	(T0,	0%	lysis,	background).	Optical	density	
of free hemoglobin was measured at 412 nm (Infinite M1000 spec-
trophotometer, Tecan). Lysis percentage was calculated as follows: 
(OD sample−ODT0)
(ODT100−ODT0)
×100.
2.7 | Cell activation assays
Porcine cells cultured on gelatin-coated 6-channel µ slides (ibidi) 
were stimulated by adding ATP or human serum in different con-
centrations (as indicated in the different experiments) after wash-
ing	twice	with	HEPES.	Changes	in	intracellular	calcium,	indicated	
by an increase of the Case12 signal, were measured using a fluo-
rescence detection system (Till Photonics), which emitted light at 
480 nm and detected the fluorescence signal (at about 505 nm, 
arbitrary units) by using a digital camera. Images of areas (240 µm 
× 320 µm) were stored every 500 ms (ATP) or 125 ms (serum) for 
75 s. Cells were counted as cells with an increased calcium level 
when the mean value of the ratio (fluorescence after stimulation/
baseline fluorescence; calculated by the software for individual 
cells) increased by at least 5 au. The percentage of cells showing 
an increased calcium concentration (% responding cells) and the 
maximal response (maximum fluorescence—baseline fluorescence) 
was	calculated	and	taken	as	rate	of	cell	responsiveness.	Data	were	
corrected for bleaching by subtracting the changes of fluores-
cence obtained in control experiments where nothing was added 
to the cells.
3  | RESULTS
3.1 | Generation of Case12 transgenic pigs
Two	SCNT/ET	experiments	using	Case12	 transgenic	 fibroblasts	as	
donor cells resulted in pregnancies, delivering a total of 12 cloned 
Case12 transgenic piglets. Primary fibroblasts were isolated from 
the ear and primary aortic endothelial cells were isolated from the 
ascending	aorta.	Expression	of	Case12	was	confirmed	in	protein	ex-
tracts	from	the	cells	by	Western	blotting	(Figure	1B)	and	by	the	basic	
fluorescence	of	genetically	modified	PAEC	at	an	unstimulated	stage	
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(Figure 1C). The amount of Case12 differed between the respec-
tive founder animals, reflecting the general diversity of transgene 
expression in additive gene transfer. Activation experiments were 
conducted in different cell lines, but as the founder 9822 showed 
highest expression levels of Case12 and thus allowed the most sensi-
tive detection of Ca2+-influx into the cytoplasm, the following data 
are shown from this cell line as a representative for genetically en-
coded Ca2+-sensing.
3.2 | Activation response of Case12 PAEC to 
different stimuli
The principal function of Case12 as a Ca2+-sensor was proved by 
stimulating	 transgenic	 PAEC	 with	 biologically	 relevant	 compo-
nents. First, we challenged cells with different concentrations of 
ATP (Figure 2A) and revealed a dose-dependent response reach-
ing a saturation plateau between 100 and 300 µM. The procedure 
was repeatable several times, albeit with a shrinking signal inten-
sity	 (Figure	2B).	 Interestingly,	 the	PAEC	did	not	react	 to	histamine	
(Figure 2A). This is in contrast to primary fibroblasts, in which both 
ATP and histamine induced profound Ca2+-influx into the cells 
(Figure 2C), although the increase of fluorescence signal was much 
slower in the latter.
More importantly, however, not all cells responded in the same 
manner to ATP stimulation, but revealed signal courses that were 
rather	 sequential	 and	 graduated	 (Figure	 3A,	 Video	 S1,	 Figure	 S1).	
Apparently, within a given window of examination, cells typically 
responded in the following manner: Initially, a driver cell reacted 
and generally showed the brightest and most sustained signal, and 
then, the other cells reacted with some delay but did not reach the 
same fluorescence intensity as the driver cell. Often cells showed 
Ca2+-influx one after the other, as in a serial connection. Of note, 
the differential fluorescent signaling was confirmed when the signal 
intensities of single cells were measured quantitatively (Figure 3B). 
While	most	of	 the	cells	 reacted	within	a	very	 short	 time-frame	 to	
ATP, the peak altitude they reached was apparently different and the 
signal decline was variable, revealing different slopes and occasion-
ally also a fluctuating decline of fluorescence.
3.3 | Effect of manipulated human serum on 
PAEC activation
Transgenic	 porcine	 EC	 reacted	 profoundly	 but	 transiently	 to	 ATP,	
with the signal in single cells returning to baseline level mostly within 
a few seconds (Figure 3B). This was in contrast to the stimulation 
of	 Case12-transgenic	 EC	 with	 human	 serum,	 the	 standard	 chal-
lenge	applied	 to	EC	 in	 the	xenotransplantation	context	 (Video	S2;	
Figure 4), where many cells exhibited elevated calcium levels for 
longer than the observation period. The difference between cells 
was pronounced, showing strongly reacting cells with a much higher 
fluorescent	signal,	as	compared	to	stimulation	with	ATP	(Serum	1/5:	
mean amplitude 77 ± 3au, individual amplitudes up to 130 au, n = 10 
vs 100 µM ATP: mean amplitude 38 ± 4 au, individual amplitudes up 
to 80 au, n = 15). On the other hand, a significant proportion of cells 
displayed only very weak, if any, reaction to human serum, which 
was confirmed by quantitative single-cell analysis. This difference in 
responses may be attributed to the more complex nature of stimuli 
in human serum, compared to a defined single molecular component 
such as ATP.
To investigate which components within serum are the main 
drivers	 of	 EC	 activation,	 the	 serum	 was	 treated	 either	 by	 heat	
inactivation to eliminate complement-mediated cytotoxicity 
(Figure 5A), or by depleting anti-aGal antibodies (Figure 5B), which 
are the dominant activators of the complement system in HAR. In 
standard dilutions of 1/10 human serum in culture medium, acti-
vation	of	EC	in	the	presence	of	heat-inactivated	serum	was	similar	
to untreated serum, whereas the response to antibody-depleted 
serum (with or without heat inactivation) was significantly lower, 
based	on	the	mean	fluorescence	 intensity	 (Figure	5C).	When	ex-
amined at cellular resolution, it was evident that in the latter case 
only a minority (approx. 20%) of the cells showed any response, 
whereas almost all cells responded to either ATP, untreated 
serum,	or	heat-inactivated	serum.	Stimulation	of	Case12	cells	with	
higher concentrations of human serum produced a similar picture 
(Figure	5D),	albeit	with	some	minor	changes:	First,	heat	inactiva-
tion showed a reduction in fluorescence intensity, but not in the 
number of cells responding, and second, the overall stimulatory 
potential of antibody-depleted serum was reduced, but to a lesser 
extent than in the 1/10 serum dilutions.
4  | DISCUSSION
Our study illustrates that genetic modification of pigs is not only 
relevant for tailoring donor animals for xenotransplantation, but 
might also have value for producing reporter pigs to gain more de-
tailed insight into physiological and pathophysiological processes. 
Although one would nowadays consider generating such models by 
using state-of-the-art technologies such as gene editing,39 conven-
tional additive gene transfer still serves the purpose. The consider-
able effort required to examine founder animals for their expression 
potential can be ameliorated by the use of a ubiquitously active 
transgene promoter that facilitates initial characterization at a cel-
lular level. Further, the chosen promoter also allows the examination 
of Ca2+-activation in other cell types. Although some of the more 
recent genetically modified Ca2+-sensors might provide higher sen-
sitivity or lower background signal,40,41 the Case12 sensor employed 
here fulfilled the expectations for exploring activation of pig primary 
endothelial cells.
A	 prominent	 finding	 was	 that	 not	 all	 PAEC	 behaved	 equally	
upon stimulation with ATP and they failed to react upon histamine 
application. A simple explanation for this might be the sequential 
loss of specific receptors during in vitro culture, but a similar diver-
sity in the activation potential has also been shown for endothelial 
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cells in ex-vivo vessel systems.31	 The	 apparent	 diversity	 of	 EC	
activation is consistent with the current interpretation of “endo-
thelial cells” as an umbrella term for cell (sub)types coating the 
luminal	 side	of	a	vessel.	 It	has	become	evident	 that	EC	diversity	
not only refers to the different vessel types in distinct tissues, but 
also to differences between endothelial cells in a local context. A 
substantial	clue	was	the	initial	discrimination	of	EC	by	the	expres-
sion of classical markers such as TBM.42	 Since	 then,	 endothelial	
subtypes have been discriminated at a broader molecular level by 
single-cell transcriptome profiling.24 Although the consequences 
of this unexpected diversity and the underlying regulatory circuits 
remain elusive, this is in line with the increasing acknowledgment 
of diversity of other cell types and their Ca2+-mediated signal 
transduction, such as epithelial cells.43
These	divergent	properties	of	individual	EC	also	cast	doubt	on	
the popular use of immortalized endothelial cell lines, including 
those derived from different endothelial sources in the pig 44-47 
Although	such	cells	might	carry	essential	markers	of	EC	and	match	
hallmarks of endothelial function, they lack the diversity of pri-
mary cells. Furthermore, the immortalization process itself and ex-
tended in vitro cultivation will impact endothelial physiology. On 
the other hand, the use of immortalized cells in high-throughput 
assays is attractive, and in such assays it might be useful to equip 
them with a genetically encoded Ca2+-sensor. From a long-term 
perspective, however, we propose that isolating large batches of 
different primary cell populations from genetically modified pigs 
will better resemble the in vitro counterpart of the in vivo situation.
Another relevant aspect of our study was the finding that 
human serum had a much more pronounced effect on individual 
EC	 than	 ATP,	 which	 might	 be	 related	 to	 the	 complex	 composi-
tion of biologically active agents in the serum, compared to the 
unambiguous	structure	of	ATP.	The	sustained	activation	of	PAEC	
over minutes, however, is remarkable, when the fast, but transient 
Ca2+-influx	after	ATP	stimulation	is	taken	into	account.	Even	more	
F I G U R E  2  Stimulating	Case12	cells	with	biologically	active	components.	(A)	In	PAEC,	ATP	showed	a	concentration	dependent	
stimulation up to a saturation plateau reached at 100-300µM ATP, whereas stimulation with histamine did not result in Ca2+-influx. (B) 
Repeated	stimulation	of	PAEC	with	100mM	ATP	(stim1,	stim2,	stim3)	resulted	in	a	sequential	decrease	of	the	calcium	influx	into	the	cells.	
(C) In contrast, fibroblasts were stimulated by both, ATP and histamine, albeit for the latter the reaction appeared slower, indicated by a 
significantly lower slope of the signal. The slope was calculated at the inflexion point of the time course of the cellular calcium rise
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F I G U R E  3  Time	course	of	Case12-PAEC	stimulation	by	ATP.	(A)	Upon	administration	of	ATP	to	the	culture	medium,	pictures	were	taken	
at	regular	intervals.	(B)	When	specifying	signals	from	single	cells,	it	appeared	that	the	increase	of	the	signal	took	place	within	a	relatively	
short interval, whereas the peak heights reached were different and the decline of the signal followed different courses
F I G U R E  4  Stimulation	of	Case12-PAEC	with	human	serum.	Both	the	overall	time	lapse	and	the	single-cell	signals	revealed	a	diverse	
pattern	of	EC	response	on	human	serum,	spanning	highly	responding	and	long	sustained	signals	to	almost	no	reaction
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surprising	was	 the	 finding	 that	 antibody	deposition	on	EC	alone,	
but not the abundance of complement in the medium alone, is suf-
ficient	to	activate	endothelial	cells.	The	reduced	activation	of	EC	
in the presence of inactivated complement at higher serum con-
centrations supports the idea that the alternative and lectin-based 
pathways might play a relevant role in endothelial activation,18 but 
we have to consider that a content of 20% serum in the culture 
medium is unusually high for in vitro experiments and might, thus, 
contribute	some	artifacts.	We	interpret	our	findings	such	that	the	
classical, antibody-mediated activation of the complement system 
is	 the	 dominating	 factor	 in	 EC	 activation	 when	 challenged	 with	
human serum.
Although our data give insight into the process of endothelial 
cell responses to xenorelevant stimulation, it would be interesting 
to examine the impact of existing and proven approaches to pre-
vent antibody-mediated rejection, such as the GTKO.hCRP.hTBM 
genetic modifications. In this context, however, it would not only be 
necessary to combine the genetically encoded Ca2+-sensor with the 
F I G U R E  5   Modification of human serum. (A) Cytotoxicity of serum was completely abolished by heat inactivation and (B) antibody 
depletion reduced the levels of anti-αGal	IgM	and	IgG	to	a	level	<	5%.	(C)	Stimulation	with	10%	serum	revealed	that	only	antibody-depleted	
serum	reduced	the	overall	fluorescence	intensity	as	well	as	the	proportion	of	reacting	cells.	(D)	When	serum	concentration	was	increased	
to 20%, the number of cells reacting on antibody-depleted serum increased, whereas the fluorescence intensity decreased, compared to 
untreated human serum
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triple modification, but it would be important to analyze such cells in 
3D-culture	assays	under	continuous	or	pulsatile	flow,	ideally	not	only	
with	plasma,	but	also	with	whole	blood.	Eventually,	such	an	innovative,	
complex, and high-throughput enabling setup may greatly facilitate 
the further improvement of vascularized xenogeneic organs or tissues.
In summary, we present here a powerful tool for evaluating ef-
fects that activate the porcine endothelium. In a proof-of-concept, 
we report that antibody depletion alone, but not complement inac-
tivation, is sufficient to significantly reduce the activation status of 
endothelial cells in the presence of human serum.
ACKNOWLEDG EMENTS
This work was supported by funding from the German Research 
Foundation (CRC127: xenotransplantation from bench to bedside). 
Work	performed	by	RS	and	RR	was	 funded	by	 the	Swiss	National	
Science	 Foundation	 (310030_182264).	 We	 thank	 Prof.	 Nicolai	
Bovin	from	the	Shemyakin	and	Ovchinnikov	Institute	for	Bioorganic	
Chemistry,	RAS,	Moscow,	Russia,	for	providing	anti-Gal	immunoab-
sorption	material	and	coating	conjugates	for	ELISA.
CONFLIC T OF INTERE S T
The authors declare that they have no conflicts of interest.
AUTHOR CONTRIBUTION
AW	designed	the	study,	performed	genetic	modification	of	primary	
cells, cultivated endothelial cells, and performed activation assays. 
PK	and	EMJ	performed	activation	assays.	RS	and	RR	performed	an-
tibody depletion, complement standard activity test, and anti-aGal 
ELISA.	AB	performed	work	on	pigs	and	 isolated	tissue	for	primary	
cell	cultivation.	MK	and	BK	performed	SCNT	and	ET.	EK	provided	
Western	blot	data.	BR	and	CK	supported	design	of	 the	study.	EW	
supported design of the study and contributed to writing of the 
manuscript. NK designed the study, designed and constructed the 
modification vector and wrote the manuscript.
ORCID
Riccardo Sfriso  https://orcid.org/0000-0002-3406-0736 
Andrea Bähr  https://orcid.org/0000-0001-8075-8222 
Robert Rieben  https://orcid.org/0000-0003-4179-8891 
Nikolai Klymiuk  https://orcid.org/0000-0002-7269-430X 
R E FE R E N C E S
	 1.	 Dalmasso	 AP,	 Vercellotti	 GM,	 Fischel	 RJ,	 Bolman	 RM,	 Bach	 FH,	
Platt	 JL.	Mechanism	of	 complement	 activation	 in	 the	hyperacute	
rejection of porcine organs transplanted into primate recipients. Am 
J Pathol. 1992;140(5):1157-1166.
	 2.	 Platt	 JL,	 Vercellotti	 GM,	 Dalmasso	 AP,	 et	 al.	 Transplantation	
of discordant xenografts: a review of progress. Immunol Today. 
1990;11(12):450-456.
	 3.	 Platt	 JL,	 Holzknecht	 ZE.	 Porcine	 platelet	 antigens	 recognized	
by human xenoreactive natural antibodies. Transplantation. 
1994;57(3):327-335.
	 4.	 McCurry	KR,	Kooyman	DL,	Alvarado	CG,	et	al.	Human	complement	
regulatory proteins protect swine-to-primate cardiac xenografts 
from humoral injury. Nat Med. 1995;1(5):423-427.
	 5.	 Cowan	PJ,	Aminian	A,	Barlow	H,	et	al.	Renal	xenografts	 from	tri-
ple-transgenic pigs are not hyperacutely rejected but cause co-
agulopathy in non-immunosuppressed baboons. Transplantation. 
2000;69(12):2504-2515.
	 6.	 Dai	 Y,	 Vaught	 TD,	 Boone	 J,	 et	 al.	 Targeted	 disruption	 of	 the	 al-
pha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol. 
2002;20(3):251-255.
	 7.	 Lai	L,	Kolber-Simonds	D,	Park	KW,	et	al.	Production	of	alpha-1,3-ga-
lactosyltransferase knockout pigs by nuclear transfer cloning. 
Science. 2002;295(5557):1089-1092.
	 8.	 Wuensch	A,	Baehr	A,	Bongoni	AK,	et	al.	Regulatory	sequences	of	
the	 porcine	 THBD	 gene	 facilitate	 endothelial-specific	 expression	
of bioactive human thrombomodulin in single- and multitransgenic 
pigs. Transplantation. 2014;97(2):138-147.
	 9.	 Bongoni	 AK,	 Klymiuk	N,	Wolf	 E,	 Ayares	D,	 Rieben	 R,	 Cowan	 PJ.	
Transgenic expression of human thrombomodulin inhibits hmgb1-in-
duced porcine aortic endothelial cell activation. Transplantation. 
2016;100(9):1871-1879.
	10.	 Mohiuddin	 MM,	 Singh	 AK,	 Corcoran	 PC,	 et	 al.	 Chimeric	 2C10R4	
anti-CD40	 antibody	 therapy	 is	 critical	 for	 long-term	 survival	 of	
GTKO.hCD46.hTBM	pig-to-primate	cardiac	xenograft.	Nat Commun. 
2016;7:11138.
 11. Längin M, Mayr T, Reichart B, et al. Consistent success in life-supporting 
porcine cardiac xenotransplantation. Nature. 2018;564(7736):430-433.
	12.	 Kim	SC,	Mathews	DV,	Breeden	CP,	et	al.	Long-term	survival	of	pig-
to-rhesus	macaque	 renal	 xenografts	 is	 dependent	 on	 CD4	 T	 cell	
depletion. Am J Transplant. 2019;19(8):2174-2185.
	13.	 Singh	AK,	Chan	JL,	DiChiacchio	L,	et	al.	Cardiac	xenografts	show	re-
duced survival in the absence of transgenic human thrombomodulin 
expression in donor pigs. Xenotransplantation. 2019;26(2):e12465.
 14. Burdorf L, Azimzadeh AM, Pierson RN 3rd. Progress and challenges 
in lung xenotransplantation: an update. Curr Opin Organ Transplant. 
2018;23(6):621-627.
 15. Zhang X, Li X, Yang Z, et al. A review of pig liver xenotransplan-
tation: Current problems and recent progress. Xenotransplantation. 
2019;26(3):e12497.
	16.	 Laird	CT,	Hassanein	W,	O'Neill	NA,	et	al.	P-	and	E-selectin	recep-
tor antagonism prevents human leukocyte adhesion to activated 
porcine endothelial monolayers and attenuates porcine endothelial 
damage. Xenotransplantation. 2018;25(2):e12381.
	17.	 Peng	Q,	 Yeh	H,	Wei	 L,	 et	 al.	Mechanisms	 of	 xenogeneic	 baboon	
platelet aggregation and phagocytosis by porcine liver sinusoidal 
endothelial cells. PLoS ONE. 2012;7(10):e47273.
	18.	 Bongoni	AK,	Kiermeir	D,	Jenni	H,	et	al.	Activation	of	the	lectin	path-
way of complement in pig-to-human xenotransplantation models. 
Transplantation. 2013;96(9):791-799.
	19.	 al-Mohanna	F,	Collison	K,	Parhar	R,	Kwaasi	A,	Meyer	B,	Saleh	S,	 ,	
et al. Activation of naive xenogeneic but not allogeneic endothelial 
cells by human naive neutrophils: a potential occult barrier to xeno-
transplantation. Am J Pathol. 1997;151(1):111-120.
	20.	 Goodman	 DJ,	 Von	 Albertini	 M,	 Willson	 A,	 Millan	 MT,	 Bach	 FH.	
Direct	activation	of	porcine	endothelial	cells	by	human	natural	killer	
cells. Transplantation. 1996;61(5):763-771.
 21. Kourtzelis I, Ferreira A, Mitroulis I, et al. Complement inhibition in a 
xenogeneic model of interactions between human whole blood and 
porcine endothelium. Horm Metab Res. 2015;47(1):36-42.
 22. Gao H, Liu L, Zhao Y, et al. Human IL-6, IL-17, IL-1beta, and TNF-alpha 
differently regulate the expression of pro-inflammatory related 
genes, tissue factor, and swine leukocyte antigen class I in porcine 
aortic endothelial cells. Xenotransplantation. 2017;24(2):e12291.
	23.	 Bongoni	AK,	Salvaris	E,	Nordling	S,	et	al.	Surface	modification	of	pig	
endothelial cells with a branched heparin conjugate improves their 
compatibility with human blood. Sci Rep. 2017;7(1):4450.
	24.	 Khan	S,	Taverna	F,	Rohlenova	K,	et	al.	EndoDB:	a	database	of	endothelial	
cell transcriptomics data. Nucleic Acids Res.	2019;47(D1):D736-D744.
10 of 10  |     WUENSCH Et al.
	25.	 Mannino	RG,	Myers	DR,	Ahn	B,	et	al.	Do-it-yourself	in	vitro	vascu-
lature that recapitulates in vivo geometries for investigating endo-
thelial-blood cell interactions. Sci Rep. 2015;5:12401.
	26.	 Sfriso	R,	Zhang	S,	Bichsel	CA,	et	al.	3D	artificial	round	section	mi-
cro-vessels to investigate endothelial cells under physiological flow 
conditions. Sci Rep. 2018;8(1):5898.
	27.	 Eccles	 SA,	 Court	W,	 Patterson	 L.	 In	 vitro	 assays	 for	 endothelial	
cell functions required for angiogenesis: proliferation, motility, 
tubular differentiation, and matrix proteolysis. Methods Mol Biol. 
2016;1430:121-147.
	28.	 Evans	 IM,	 Kennedy	 SA,	 Paliashvili	 K,	 et	 al.	 Vascular	 Endothelial	
Growth	Factor	(VEGF)	promotes	assembly	of	the	p130Cas	interac-
tome to drive endothelial chemotactic signaling and angiogenesis. 
Mol Cell Proteomics. 2017;16(2):168-180.
	29.	 Le	Guelte	A,	Gavard	J.	Role	of	endothelial	cell-cell	junctions	in	en-
dothelial permeability. Methods Mol Biol. 2011;763:265-279.
	30.	 Biwer	LA,	Lechauve	C,	Vanhoose	S,	Weiss	MJ,	 Isakson	BE.	A	cell	
culture model of resistance arteries. J Vis Exp. 2017;(127):e55992.
	31.	 Kameritsch	P,	Pogoda	K,	Ritter	A,	Munzing	S,	Pohl	U.	Gap	junctional	
communication controls the overall endothelial calcium response to 
vasoactive agonists. Cardiovasc Res. 2012;93(3):508-515.
	32.	 Souslova	EA,	Belousov	VV,	Lock	JG,	et	al.	Single	fluorescent	pro-
tein-based Ca2+ sensors with increased dynamic range. BMC 
Biotechnol. 2007;7:37.
	33.	 Bähr	 A,	 Käser	 T,	 Kemter	 E,	 et	 al.	 Ubiquitous	 LEA29Y	 expression	
blocks T cell co-stimulation but permits sexual reproduction in ge-
netically modified pigs. PLoS ONE. 2016;11(5):e0155676.
	34.	 Klymiuk	 N,	 Böcker	W,	 Schönitzer	 V,	 et	 al.	 First	 inducible	 trans-
gene expression in porcine large animal models. FASEB J. 
2012;26(3):1086-1099.
 35. Richter A, Kurome M, Kessler B, et al. Potential of primary kidney 
cells for somatic cell nuclear transfer mediated transgenesis in pig. 
BMC Biotechnol. 2012;12:84.
	36.	 Kurome	 M,	 Kessler	 B,	 Wuensch	 A,	 Nagashima	 H,	 Wolf	 E.	
Nuclear transfer and transgenesis in the pig. Methods Mol Biol. 
2015;1222:37-59.
	37.	 Gerber	B,	Tinguely	C,	Bovin	NV,	Rieben	R,	Nydegger	UE.	Differences	
between synthetic oligosaccharide immunoabsorbents in depletion 
capacity for xenoreactive anti-Galalpha1-3Gal antibodies from 
human serum. Xenotransplantation. 2001;8(2):106-114.
	38.	 Rieben	R,	Korchagina	EY,	Allmen	EV,	et	al.	In	vitro	evaluation	of	the	
efficacy and biocompatibility of new, synthetic ABO immunoabsor-
bents. Transplantation. 1995;60(5):425-430.
	39.	 Klymiuk	N,	Seeliger	F,	Bohlooly	YM,	Blutke	A,	Rudmann	DG,	Wolf	
E.	Tailored	pig	models	for	preclinical	efficacy	and	safety	testing	of	
targeted therapies. Toxicol Pathol. 2016;44(3):346-357.
	40.	 Chen	T-W,	Wardill	TJ,	Sun	YI,	et	al.	Ultrasensitive	fluorescent	proteins	
for imaging neuronal activity. Nature. 2013;499(7458):295-300.
	41.	 Inoue	 M,	 Takeuchi	 A,	 Horigane	 S-I,	 et	 al.	 Rational	 design	 of	 a	
high-affinity, fast, red calcium indicator R-CaMP2. Nat Methods. 
2015;12(1):64-70.
	42.	 Weiler-Guettler	H,	Aird	WC,	Husain	M,	Rayburn	H,	Rosenberg	RD.	
Targeting of transgene expression to the vascular endothelium of 
mice by homologous recombination at the thrombomodulin locus. 
Circ Res. 1996;78(2):180-187.
	43.	 Birchenough	 GM,	 Nystrom	 EE,	 Johansson	 ME,	 Hansson	 GC.	 A	
sentinel goblet cell guards the colonic crypt by triggering Nlrp6-
dependent Muc2 secretion. Science. 2016;352(6293):1535-1542.
 44. Chrusciel M, Bodek G, Kirtiklis L, et al. Immortalization of swine 
umbilical	vein	endothelial	cells	 (SUVECs)	with	the	simian	virus	40	
large-T antigen. Mol Reprod Dev. 2011;78(8):597-610.
	45.	 Kim	D,	Kim	J,	Koh	H,	et	al.	Establishment	and	characterization	of	
endothelial cell lines from the aorta of miniature pig for the study of 
xenotransplantation. Cell Biol Int. 2005;29(8):638-646.
	46.	 Kuruvilla	L,	Tr	S,	Kartha	CC.	 Immortalization	and	characterization	
of porcine ventricular endocardial endothelial cells. Endothelium. 
2007;14(1):35-43.
	47.	 Seebach	 JD,	 Schneider	 MKJ,	 Comrack	 CA,	 et	 al.	 Immortalized	
bone-marrow derived pig endothelial cells. Xenotransplantation. 
2001;8(1):48-61.
SUPPORTING INFORMATION
Additional supporting information may be found online in the 
Supporting	Information	section.			
How to cite this article:	Wuensch	A,	Kameritsch	P,	Sfriso	R,	
et al. Genetically encoded Ca2+-sensor reveals details of 
porcine endothelial cell activation upon contact with human 
serum. Xenotransplantation. 2020;00:e12585. https ://doi.
org/10.1111/xen.12585 
